Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications

Expert Opin Drug Deliv. 2016 Sep;13(9):1301-9. doi: 10.1080/17425247.2016.1182492. Epub 2016 May 11.

Abstract

Introduction: Progress in drug delivery and a better quality of life for patients, relies on the development of new and suitable drug carrier systems, with unequivocal therapeutic benefits, low systemic toxicity and reduced side effects. Lipid-polymeric nanoparticles have been explored to produce nanocarriers due to their features and applications such as high drug entrapment, physical-chemical stability and controlled release properties.

Areas covered: In this review, we describe several hybrid nanoparticles obtained from mixing a polymer with a lipid matrix. This association can potentiate the efficacy of drug delivery systems, due to the enhancement of encapsulation efficiency and loading capacity, tailoring the drug release according to the therapeutic purpose, and improving the drug uptake by targeting it to specific receptors. Contrary to lipid nanoparticles, these hybrid nanoparticles can decrease the initial burst release and promote a more sustained and localized release of the drug.

Expert opinion: Lipid-polymeric nanoparticles are versatile vehicles for drug delivery by different administration routes in the treatment of multiple diseases. Different solid lipids, polymers, surfactants and techniques for producing these carriers have been investigated, revealing the importance of their composition to achieve optimal characteristics to drug delivery.

Keywords: Hybrid nanoparticle; lipid; lipid-polymeric nanoparticle; nanoparticle; polymer.

Publication types

  • Review

MeSH terms

  • Drug Carriers / chemistry
  • Drug Delivery Systems*
  • Excipients / chemistry
  • Humans
  • Lipids / chemistry*
  • Nanoparticles
  • Polymers / chemistry*
  • Quality of Life
  • Surface-Active Agents / chemistry

Substances

  • Drug Carriers
  • Excipients
  • Lipids
  • Polymers
  • Surface-Active Agents